Zimbabwe has rejected a major US healthcare agreement valued at $367m (£272m) spanning five years due to the United States' insistence on sensitive biological samples.
This rejection came to light following a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official spokesperson has since stated that the United States was requesting health data for research and profit while was not willing to share the benefits from future vaccines.
"We are forced to start the difficult and regrettable process of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged further dialogue to find a deal agreeable to all parties so the country's critical HIV treatment initiative can be sustained.
Broader Context
This development comes after a comparable situation in neighbouring Kenya, where a court suspended a related health funding agreement after legal challenges were filed about the security of Kenyans' medical information.
After resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump stated its spending was "inefficient" and his government was seeking direct bilateral agreements to boost transparency and responsibility.
As per reports, 16 African countries have to date agreed to these new health pacts, representing over $18.3bn in new funding.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million currently receiving HIV treatment via American-funded programmes," Tremont commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, without any corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Effectively, our nation would supply the raw materials for scientific discovery with no certainty that the final treatments would be available to our citizens should a new health crisis emerge."
National Interest and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting systems previously established through the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to manage future global health emergencies.
"This mechanism is intended to ensure that when a country provides its samples, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to develop them."
These objections over the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome further discussions with our American counterparts on how subsequent co-operation could be arranged in a way that respects the sovereignty and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but suggested that talks must proceed considering a large portion of the nation's HIV programmes relied on foreign aid.
"Where technical issues arise, including those relating to data governance or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," the group said.
This impasse underscores the ongoing tensions between accepting crucial international aid and safeguarding a country's data in an ever more data-driven world.